Docket
117th Congress · HOUSE RESOLUTIONBILL

H.Res. 1434 — Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.

“Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.”

Health
Introduced Oct 14, 2022
Last action Dec 21, 2022
Pipeline · Resolution
Step 1
Introduced
Oct 14, 2022
Step 2
Referred
Oct 17, 2022
E&C · Judiciary
Step 3
Committee
Step 4
House floor
Dec 21, 2022
Agreed to in House
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 0 sections
No provisions parsed for this bill.
Timeline · 5 actions
Dec 21, 2022
Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
Oct 17, 2022
Referred to the Subcommittee on Health.
Oct 14, 2022
Introduced in House
Oct 14, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 14, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.